Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The study of atherosclerosis with ramipril and rosiglitazone.

Trial Profile

The study of atherosclerosis with ramipril and rosiglitazone.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2009

At a glance

  • Drugs Ramipril; Rosiglitazone
  • Indications Atherosclerosis; Glucose intolerance
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms STARR
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Jun 2009 Primary endpoint 'Intima media thickness' has not been met, according to results published in the Journal of the American College of Cardiology.
    • 02 Jun 2009 Results published in the Journal of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top